GlassScriptPhysician profile
Melissa B Hanish
NPI 1679914154
$751.02
in general payments reported to CMS, 2019-2025
15 companies · $83.21 in 2025
The $83.21 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $96.06 · 2023: $364 · 2024: $208 · 2025: $83.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $169.93 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alexion Pharmaceuticals, INC. | $125.00 | 2023 | |
| Glaxosmithkline, LLC. | $113.19 | 2023 | Arexvy |
| Pfizer INC. | $71.43 | 2022-2024 | |
| Kestra Medical Technology Services, INC. | $52.57 | 2024-2025 | Assure Wcd |
| Cvrx, INC. | $37.56 | 2024 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $33.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.43 | 2023 | Camzyos, Eliquis |
| Stryker Corporation | $21.25 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Innovation Technologies INC | $19.01 | 2024 | Irrisept |
| Chiesi USA, INC. | $18.65 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.32 | 2024 | Lifevest |
| Medtronic, INC. | $14.65 | 2022 | |
| Merck Sharp & Dohme LLC | $13.29 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.74 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hanish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.